Epidemiologist: Don’t Procrastinate and Be Picky Vaccine Brands

People should get vaccinated as soon as they get the chance.

REPUBLIKA.CO.ID,JAKARTA — Epidemiologist from the Faculty of Public Health, University of Indonesia (FKM UI) Iwan Ariawan appealed to the public to immediately follow suit vaccination Covid-19 with any brand. If not later there is a risk that must be borne for delaying vaccine and busy picky brands.

“There is a risk of being infected” Covid-19 because they delay vaccination. This is because the number of Covid-19 cases is still high.

Vaccination is one of the most effective ways to prevent us from getting infected and reduce the risk of getting sick. All brands Covid-19 vaccine used in Indonesia has passed expert studies and BPOM,” he said on Sunday (12/9).

Then, he continued, all vaccines have been proven to be effective and safe. So, people should immediately vaccinate when they get the chance. “There are people who choose vaccine brands because they are influenced by information about the effectiveness of vaccines, various side effects and hoaxes,” he said.

Meanwhile, Epidemiologist from the Faculty of Medicine, Public Health and Nursing (FKKMK) Universitas Gadjah Mada, Riris Andono Ahmad, assessed that there are many reasons why people are picky about vaccine brands.

“Probably because of the information circulating regarding each vaccine,” he said.

He assessed the risk that people who continue to be picky about vaccine brands are infected with the Covid-19 virus until they experience severity. Riris said that currently available vaccines in Indonesia are the best vaccines.

“The sooner it is vaccinated, the risk of experiencing severe Covid-19 will be avoided,” he said.

Previously, the Spokesperson for the Covid-19 Vaccination of the Ministry of Health, Siti Nadia Tarmizi, admitted that some people are picky about vaccine brands. Generally, people are picky about vaccine brands because of hoaxes about side effects.

He hopes that people will immediately follow the vaccine with any brand. To get out of the pandemic and of course so as not to face the threat of virus variants.

“So, we must together have protection or immunity to be able to fight together,” he said.

Indonesia has brought in as many as 225.4 million doses of vaccine. The details are 33 million doses of Sinovac vaccine in finished form, 153.9 million doses of Sinovac in bulk, 19.5 million doses of AstraZeneca, 8 million doses of Moderna, 2.75 million doses of Pfizer, and 8.25 million doses of Sinopharm.

As of Saturday, September 11, as many as 72,248,720 people have received the first dose of vaccine, 41,534,340 received the second dose of vaccine, and 775,725 have received the third dose of vaccine. The target of the national vaccination program is 208,265,720 people.

– .